Weaver Consulting Group’s Nu Skin NUS Stock Holding History

Weaver Consulting Group’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-90	Closed	-$5K	–	636
2020 Q3	$5K	Sell	90 -70	-44%	-$3.32K	﹤0.01%	693
2020 Q2	$6K	Hold	160	–	–	﹤0.01%	634
2020 Q1	$4K	Hold	160	–	–	﹤0.01%	612
2019 Q4	$7K	Hold	160	–	–	﹤0.01%	557
2019 Q3	$7K	Hold	160	–	–	﹤0.01%	535
2019 Q2	$8K	Hold	160	–	–	﹤0.01%	504
2019 Q1	$8K	Buy	+160	New	+$9.7K	﹤0.01%	1002

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Weaver Consulting Group's NUS Position: Q4 2020 in Review

Weaver Consulting Group sold out of Nu Skin (NUS) in Q4 2020, closing a stake of 90 shares — an estimated $5K sold.

Weaver Consulting Group first reported a position in NUS in Q1 2019 and held it in 7 quarters. The position peaked at $8K in Q2 2019. 266 funds tracked by Wall St. Rank hold NUS as of Q4 2020.

Weaver Consulting Group reported no remaining Nu Skin position as of Q4 2020 after selling out during the quarter.
Weaver Consulting Group sold 90 Nu Skin shares in Q4 2020, an estimated $5K.
Weaver Consulting Group first reported a position in Nu Skin in Q1 2019 and held it in 7 quarters.
Weaver Consulting Group's Nu Skin position peaked at $8K in Q2 2019.
266 funds tracked by Wall St. Rank held Nu Skin as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.